RxDoctor Payments Data

Julie White

Family · Rome, GANPI 1134588916

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 27.2% of the total. Reporting peaked in 2021 at $715 and has fallen 58.3% since, to $298 in 2025.

$1,938in general payments, 2019–2025

Across 116 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$527
  • Novartis$283
  • Takeda Pharmaceuticals U.S.A., Inc.$248
  • Lilly USA, LLC$173
  • Novo Nordisk$81
  • GSK$81
  • plus $546 from 18 others

What the payments were for

  • Food & beverage$1,938100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,938 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia →

Other family in Rome

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →